University of Strasbourg
Also known as: Central Hospital, Strasbourg, France | CHRU de Strasbourg | CHRU de Strasbourg, Strasbourg, France | CHRU Strasbourg | CHU de Strasbourg | CHU strasbourg | CHU Strasbourg | CHU STRASBOURG | CISIH CHRU STRASBOURG | Hôpital Civil de Strasbourg | Hôpital de Hautepierre, University Hospital of Strasbourg | Hopitaux Universitaires de Strasbourg | Hôpitaux Universitaires de Strasbourg | Hôpitaux Universitaires de Strasbourg - Service de chirurgie du rachis | IHU Strasbourg | Institut de Physiologie, Strasbourg, France | Institut Pluridisciplinaire Hubert Curien, Strasbourg, France | Laboratoire de Psychologie des Cognitions (Strasbourg University) | Les Hôpitaux Universitaires de Strasbourg | Service Chirurgie Digestive et Endocrinienne, Nouvel Hôpital Civil de Strasbourg | Service de Chirurgie Digestive et Endocrinienne, NHC, Strasbourg | Strasbourg (FR), University College Hospital | Strasbourg Hospital : Civil Hospital | Strasbourg - NHC | STRASBOURG ONCOLOGIE LIBERALE - CLINIQUE SAINTE ANNE - Strasbourg | STRASBOURG ONCOLOGIE LIBERALE, Strasbourg | Strasbourg Universitary hospitals | Strasbourg University Hospital, France | University Hospital of Strasbourg | University Hospitals of Strasbourg | University Hospital, Strasbourg | University Hospital, Strasbourg, France
Highest phase reached
Phase 4
First clinical trial
May 1, 1998Last known activity
Mar 1, 2026
Timeline
1530s
- Jan 1, 1538
University of Strasbourg— Founded
Drugs by trial phase (121 distinct, 101 trials)
Phase 4 (38 own, 0 via acquisition)
Phase 3 (39 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adenocarcinoma
- Aggression
- Aortic Valve Stenosis
- Arthritis
- Arthritis, Rheumatoid
- Blood Loss, Surgical
- Body Weight
- Brugada Syndrome
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Charcot-Marie-Tooth Disease
- Chronic Periodontitis
- Communicable Diseases
- Constriction, Pathologic
- Coronavirus Infections
- Cross Infection
- Cystic Fibrosis
- Depression
- Depressive Disorder
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disruptive, Impulse Control, and Conduct Disorders
- Eclampsia
- Endocrine System Diseases
- Epilepsy
- Fibrosis
- Graft vs Host Disease
- Heart Failure
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hereditary Sensory and Motor Neuropathy
- HIV Infections
- Hypertension
- Hypertrophy
- Hypoalbuminemia
- Infarction
- Infections
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Mucositis
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Multiple Trauma
- Myocardial Infarction
- Myopia
- Neoplasms
- Nerve Compression Syndromes
- Neuralgia
- Neutropenia
- Osteoarthritis
- Osteoarthritis, Knee
- Pain
- Parkinson Disease
- Periodontitis
- Pneumonia
- Polycystic Ovary Syndrome
- Pre-Eclampsia
- Premature Birth
- Prostatic Neoplasms
- Proteinuria
- Psychomotor Agitation
- Recurrence
- Reperfusion Injury
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Neoplasms
- Retinoblastoma
- Rhinitis, Allergic, Seasonal
- Sclerosis
- Seizures
- Severe Acute Respiratory Syndrome
- Signs and Symptoms
- Signs and Symptoms, Respiratory
- Sjogren's Syndrome
- Subarachnoid Hemorrhage
- Syndrome
- Systemic Inflammatory Response Syndrome
- Thromboembolism
- Viremia
- Wounds and Injuries
Recent trials (50)
- NCT07214103Lead sponsorPhase 2Mar 1, 2026
- NCT06881927Lead sponsorPhase 4Feb 1, 2026
- NCT07067801CollaboratorPhase 3Nov 30, 2025
- NCT07067736Lead sponsorN/AAug 1, 2025
- NCT06906549Lead sponsorPhase 4Jul 11, 2025
- NCT06698263Lead sponsorPhase 4Mar 1, 2025
- NCT06263816CollaboratorPhase 3Nov 15, 2024
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT06012097Lead sponsorPhase 4Jan 1, 2024
- NCT06081400Lead sponsorN/ANov 30, 2023
- NCT06081400OfficialN/ANov 30, 2023
- NCT06081400Overall official - principal investigatorN/ANov 30, 2023
- NCT05832489Lead sponsorPhase 3Oct 1, 2023
- NCT05832489Overall official - principal investigatorPhase 3Oct 1, 2023
- NCT05180825Overall official - principal investigatorPhase 2May 5, 2022
Details
- Founded
- Strasbourg, FR Jan 1, 1538
- Last known activity
- Mar 1, 2026